A study led by researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has found that mutations in blood-forming cells may explain the increased ...
As blood cancers are constantly evolving and developing mutations that grow resistance to current treatments, researchers in the University of Cincinnati Cancer Center's Leukemia and Drug Development ...
ET, a chronic myeloproliferative neoplasm (MPN), is characterized by overproduction of platelets, often linked to mutations ...
Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback